Anthe Janssen | Universiteit Leiden

Anthe Janssen studied Molecular Science & Technology at the TU Delft and Leiden University, followed by an MSc in Chemistry in Leiden. He then joined the Molecular Physiology group to pursue a PhD. In this project, he worked on several medicinal chemistry and chemical biology projects, focusing on applying activity-based protein profiling to determine inhibitor selectivity in drug discovery. In the final years of his PhD, he developed a machine learning based method to predict inhibitor selectivities. This computational interest was followed up in a Postdoc partly in the group of Computation Drug Discovery of Gerard van Westen (LACDR, Leiden University). Since 2020 he has been an assistant professor at the Leiden Institute of Chemistry, focusing on applying computational methods to all aspects of early drug discovery.

An initiative of

LEIDEN DRUG DEVELOPMENT CONFERENCE

MORE INFO:
Marije Stofregen
E: lddc@hyphenprojects.nl

Organisational support by:
Congress & Event Services & Hyphen Projects

Registration is closed. 

© Copyright 2022 Leiden Drug Development Conference